'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Most patients meet the Merck Manual as a reference on a clinician’s desk; Dr. Jessica McLaughlin has written part of it. She is a co-author of the manual’s chapter on female reproductive endocrinology, the same subject she now practices — endometriosis, fibroids, ovulation induction, IVF and the fertility-preserving decisions that have to happen before cancer treatment.
She joined Coastal Fertility Specialists in the summer of 2019 after a Texas training track that kept her at one institution: an MD from Upstate Medical University in Syracuse, then OB/GYN residency at the University of Texas Health Science Center in San Antonio, where she stayed on as a clinical instructor and completed her REI fellowship. She is board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a Fellow of ACOG, and a faculty member at MUSC, where she continues to teach residents and medical students — the teaching habit she started in San Antonio.
Her published work appears in Fertility and Sterility and the Journal of Assisted Reproduction and Genetics, and she has presented at the annual meetings of ASRM and ACOG. The clinical portfolio is distinctive in one respect: oncofertility is a named research interest, which matters for a patient who has been told to consult reproductive medicine before starting chemotherapy. Patient reviews put the same emphasis on communication — one recent Google review describes arriving with a suspicion of PCOS, asking for comprehensive testing, and being helped to understand the diagnosis; another, from a paraplegic patient navigating conception with a disability, credits Dr. McLaughlin with “compassionate, patient-centered care” and support from the clinical staff “unmatched.”
Clinical Expertise
- Endometriosis-related infertility: evaluation and treatment planning, one of her stated research areas, including whether surgery or IVF comes first
- Uterine fibroids (leiomyomas): assessing whether fibroids are affecting the cavity and implantation
- Oncofertility and fertility preservation: egg and embryo freezing ahead of gonadotoxic therapy, in a clinic with a centralized embryology lab
- IVF and IUI cycle management, from stimulation through transfer, with published outcomes research in both
- Physician-patient communication in complex cases: co-author of a national clinical reference chapter on female reproductive endocrinology
Why Choose Dr. Jessica McLaughlin
She writes reference text on the subject she treats. Merck Manual co-authorship in female reproductive endocrinology is an external editorial standard, not a clinic bio adjective.
Oncofertility is a research line, not a favor. Patients facing chemotherapy or pelvic surgery get a physician who has formally studied fertility preservation timing.
A teaching record on two coasts. Clinical instructor at UT Health Science Center San Antonio after residency, now MUSC faculty, with residents and medical students in her clinics.
Named repeatedly in patient reviews. Two of the clinic’s most recent Google reviews single her out, including a patient with a physical disability who described feeling “seen and supported through the whole process.”
Professional Affiliations
Board-certified by the American Board of Obstetrics and Gynecology in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility; Fellow of the American College of Obstetricians and Gynecologists. Member of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility, with presentations at both ASRM and ACOG annual meetings. Faculty, Medical University of South Carolina. Publications in Fertility and Sterility and the Journal of Assisted Reproduction and Genetics; co-author, Merck Manual chapter on female reproductive endocrinology.
Suitable For
- Patients with endometriosis who want a staged plan rather than an automatic leap to IVF
- Cancer patients before treatment, where egg, embryo or tissue preservation has a narrow window
- Women with fibroids and a history of failed transfers or recurrent loss
- PCOS workups where comprehensive testing and a clear explanation of the diagnosis are the priority
- Patients with disabilities who need a clinic that adapts the visit, as recent reviewers describe